About Event
Thank you to our speakers, sponsors, and delegates who joined us in Boston for the 3rd Annual PAT & Real Time Quality Summit 2024! If you are interested in the 2025 event, please get in touch at info@hansonwade.com
What Happened in 2024
Are you a senior leader within the pharmaceutical and biopharmaceutical community?
Join the 3rd Annual PAT & Real Time Quality Summit to explore the latest advancements in process analytical technology and its applications across various modalities, including small molecules, peptides, vaccines, biologics, cell and gene therapy.
Returning in 2024, you had the chance to:
- Explore how to leverage AI and machine learning to optimize PAT in biopharmaceutical manufacturing
- Investigate real-time release testing and lights out manufacturing strategies
- Learn how to navigate regulatory and compliance challenges in PAT implementation and harness advanced analytical technologies.
We joined in December in Philadelphia to be a pivotal part of the revolution in drug development and manufacturing through cutting-edge PAT advancements.
Together, we were able to shape and control the future of smart drug manufacturing.
2024’s Summit Featured:
Expertise From 22+ Industry Leaders:
Learn directly from top PAT scientists, engineers, and quality experts who will share cutting-edge strategies and proven solutions to enhance your processes and accelerate development.
Solutions to Your Biggest Challenges in Real-Time:
Attend interactive workshops designed to tackle regulatory hurdles and automation implementation. Get practical tools to overcome obstacles and drive efficiency in your operations.
Unrestricted Access to the Full Agenda:
Maximize your learning with full access to the entire 2-day conference. Enjoy the key sessions related to your role and network with your peers, so you can advance your career and improve your organization’s performance.
What Your Peers Said:
"The intimacy of the event made for really open communication and networking opportunities"
Process Engineer, Sanofi
"Excellent agenda and interactions with attendees"
Chairman, Chief Executive & Scientific Officer, Lumacyte